Thailand begins production of the COVID-19 vaccine Already in the country! Ministry of Public Health Revealing the annual production capacity of 200 million doses will gradually deliver the first lot in May 2021. Including ordering the vaccine from a Chinese company Ready to negotiate additional procurement for Thai people to receive free vaccinations by the state as a target of at least 50 percent
Click to follow live news line of official account here.
January 3, 2021 At the News Operation Center for Coronavirus 2019, Ministry of Public Health Nonthaburi Province Dr. Supakit Sirilak, Director-General of the Department of Medical Sciences Along with Dr. Nakorn Premsri, director of the National Vaccine Institute and Dr. Songpol Dee Chongkit Managing Director Siam Biso Co., Ltd. Press release on the progress of the vaccine procurement of COVID 19
Dr. Supakit said that Thai Government by Ministry of Public Health Have cooperated with many parties To assure citizens that they will receive their vaccines no later than most countries. Since the middle of the past year The COVID-19 Vaccine Procurement Committee for Thai People has prepared to research, set goals, work methods, and have mechanisms to achieve the vaccine. Since the results of the research are unknown, which vaccines will be successful. Set a target for free vaccinations for Thai people of at least 50% of the population or approximately 70 million doses by entering into a 26 million dose advance subscription agreement with AstraZeneca. Which uses the technology of the University of Oxford
“Currently in the process of transferring the production process to Siam Bioscience Company Deliveries are expected to begin by the end of May. Another 30 percent are in negotiations with the COVAX Facility, concluding a deal with a vaccine company that is expected to be available. Including negotiations with other companies such as Pfizer, Moderna, Chinese companies Or may request additional purchases from AstraZeneca In addition, there is good news that 2 million doses of the vaccine will be obtained from Sinovac, China, approximately 200,000 doses in late February, 800,000 in late March and 1 million in late April. Dosages
Dr. Supakit continued that There are few vaccines at this time. Even the countries that have started injections and have started to inject them are unable to inject at once. It is not a product that is readily available in the market It is important to have a quality and safety control system. No vaccines will be purchased from substandard factories. No Phase 3 trial results are supported by private companies that will be sold and must be registered with the FDA, and most importantly, every lot that is launched in the market must be certified by the Department of Medical Sciences. It is consumer protection Which Thailand has a mechanism for considering
The committee has passed a process that confirms that the standards are adequate. To ensure that Thai people get vaccinated quickly and safely, including when they have received the vaccine Will operate according to the principles of vaccine administration There is a target audience. Methods of vaccination Service preparation Quality control From the beginning to the end
Dr. Nakhon said that There are now four types of COVID-19 vaccine approved for emergency use (EUA) worldwide. Four vaccines such as mRNA, Viral Vector, Inactivated and Sub unit protein in Thailand will accept registration at There was a phase 3 effect, and the effectiveness was obvious. Only three registered and recognized vaccines are Pfizer, Moderna and AstraZeneca. The rest (AstraZeneca) is an emergency registration using only the results of the Phase 2 trial, even the Chinese and Russian vaccines. That previously registered since Jul-Aug 2020 Still has no official phase 3 results come out And all currently available COVID-19 vaccines are not yet finalized. Both Pfizer and Modena continued to collect data to look at the effectiveness of the vaccine after three months. While AstraZeneca’s Thai subscriptions have been approved for emergency vaccine use by the British Regulatory Authority on 30 December 2020.
“More than 5 million doses of the vaccine in 10 countries around the world are due to advance vaccine reservations from July to August 2020. While making the reservation The preliminary results of studies of vaccine efficacy and safety are not known. There is a very high risk that the vaccine will not be successful and not vaccinated. For Thailand Advance reservations for Phase III vaccines, with the risk of not receiving them. Has relied on the issuance of power under the National Vaccine Security Act B.E. 2561 on 12 Oct. 2020 and has booked a vaccine in Nov. 2020 “
Dr. Nakhon said that As for the feasibility question that within Jan. By 2021 there will be more vaccinations. But will it reach a hundred million doses or not? This depends on the number of vaccines available. Since there are currently a limited number of vaccines. Every company is expanding its production capacity to fit the entire population of the world. This is a great opportunity for more information on vaccine safety. When vaccines are used in large populations This will make it more likely to experience a rare adverse reaction after vaccination. In addition, Thailand is not solely focused on AstraZeneca vaccines. The Ministry of Public Health has set a vaccine policy to cover at least 50% of the Thai population in 2021, which has been implemented in a number of ways. There are currently talks with several other vaccine manufacturers. It was not specified as to collaborate only with a particular manufacturer. No private sector is blocked from importing vaccines to the country. By following a process that must be approved by the FDA to ensure that the vaccine is effective, safe and compliant with international standards. In addition, there is a plan to support vaccine registration for use in an emergency by the FDA, which has already prepared and established guidelines for emergency registration Can ask for this information from the Food and Drug Administration
While Dr. Songpol stated that Siam Bioscience Company Received knowledge and technology from AstraZeneca Company From October 7, 2020, we have prepared the facility, plant, material, equipment, equipment, machinery, currently in the production testing phase in order to obtain good quality vaccines There is a standard equivalent to the central standard. Which is the same standard as global manufacturing plants under AstraZeneca There is a production capacity of about 200 million doses per year or 15 to 20 million doses per month will be tested in 5 production cycles, each production cycle 14 days apart and takes 120 days (4 months) to produce 60 days and 60 days for quality analysis
By producing the first round on December 16 the past Production of the second round, when the production is complete 5 rounds, the results will be submitted to the Food and Drug Administration for approval. However, the most important thing in vaccine production is quality and reliability. To make people confident in efficiency and safety This is as planned and progress will be reported periodically.
–
